Brief: Verastem Oncology Provides A Clinical Update For Ramp 203 Trial
Dec 18 (Reuters) - Verastem Inc VSTM.O :
* VERASTEM ONCOLOGY PROVIDES A CLINICAL UPDATE FOR RAMP 203
TRIAL
IN ADVANCED KRAS G12C MUTANT NON-SMALL CELL LUNG CANCER
* NO DOSE-LIMITING TOXICITIES OBSERVED IN TRIPLET
COMBINATION
Source text: ID:nBw5PpQr9a
Further company coverage: VSTM.O
((Reuters.Briefs@thomsonreuters.com;))